Foghorn Therapeutics (FHTX)
(Delayed Data from NSDQ)
$9.32 USD
-0.67 (-6.71%)
Updated Sep 23, 2024 04:00 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.41 | -19.51% |
Earnings Summary
For their last quarter, Foghorn Therapeutics (FHTX) reported earnings of -$0.45 per share, beating the Zacks Consensus Estimate of $-0.60 per share. This reflects a positive earnings surprise of 25.00%. Look out for FHTX's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.41 per share, reflecting a year-over-year decrease of 20.59%.
Earnings History
Price & Consensus
Zacks News for FHTX
Wall Street Analysts Think Foghorn Therapeutics (FHTX) Could Surge 81.16%: Read This Before Placing a Bet
FHTX: What are Zacks experts saying now?
Zacks Private Portfolio Services